Head of Oncology Clinical Development

Confidential

Philadelphia (Philadelphia County)

On-site

USD 250,000 - 400,000

Full time

10 hours ago
Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Performance bonuses

Job summary

Confidential is seeking an experienced Head of Oncology Clinical Development to lead its oncology portfolio from early development through regulatory submission and commercialization. The role requires strategic vision, deep oncology expertise, and the ability to partner with executive leadership on complex decisions.

The successful candidate will oversee trial design, regulatory strategy, and program advancement, while guiding cross-functional teams across Research, Regulatory, and Commercial

Qualifications

  • MD with oncology leadership experience.
  • Proven track record in advancing programs from early phase to approval.
  • Strong regulatory and FDA engagement experience.

Responsibilities

  • Provide medical leadership for oncology clinical development and trial design.
  • Lead regulatory strategy and interactions for BLA submission.
  • Guide early clinical development, pivotal trials, and lifecycle management.

Skills

Oncology leadership
Clinical development strategy
Clinical trial design
Regulatory strategy
Cross-functional leadership
FDA interactions

Education

MD (Medical Doctor)

Job description

Our client is an innovative, global commercial-stage biotechnology company focused on developing and delivering transformative medicines for patients with significant unmet medical needs. With an established commercial organization, a growing global presence, and a robust pipeline, the company is entering an important period of continued growth and organizational evolution.

The company combines the entrepreneurial mindset and agility of biotechnology with the increasing scale and complexity of a global commercial organization. As the business continues to grow, it is seeking an experienced Head of Oncology Clinical Development to lead its oncology clinical development programs and serve as a key advisor to the executive leadership team.

Position Overview

The Head of Oncology Clinical Development will have overall responsibility for the company's oncology clinical development strategy, clinical programs, and medical leadership across its oncology pipeline. This individual will be responsible for developing and executing comprehensive clinical development strategies capable of advancing innovative oncology therapies from first-in-human studies through pivotal clinical development, regulatory submission, approval, and commercialization.

This position requires a proven oncology development leader with the scientific expertise, clinical judgment, regulatory experience, and strategic perspective necessary to guide programs through the full development lifecycle. The successful candidate will have demonstrated experience translating early clinical findings into actionable development strategies, identifying viable paths to registration, designing and executing pivotal trials, and leading clinical development activities supporting regulatory approval and commercial launch.

This is a broad, hands-on leadership role requiring both strategic thinking and a willingness to operate directly within the business. The successful candidate will be equally comfortable advising senior executives on complex clinical, scientific, medical, and regulatory matters and working through the practical details required to advance successful oncology clinical development programs.

The role will oversee the full spectrum of oncology clinical development, including early clinical strategy, first-in-human studies, dose escalation and optimization, indication selection, clinical proof of concept, pivotal trial design and execution, regulatory interactions, clinical components of marketing applications, approval readiness, and clinical development activities supporting commercialization and lifecycle management.

Key Responsibilities
  • Serve as a trusted advisor to executive leadership on oncology clinical development strategy, scientific opportunities, clinical trial design, program prioritization, regulatory pathways, and development risks.
  • Develop and execute comprehensive oncology clinical development strategies that establish a clear and credible path from Phase I through regulatory approval and commercialization.
  • Provide strategic leadership in determining when and how programs should advance from early clinical development into pivotal and registrational studies.
  • Evaluate clinical development opportunities based on scientific rationale, unmet medical need, competitive landscape, regulatory feasibility, commercial potential, and probability of technical and regulatory success.
  • Provide thoughtful and pragmatic counsel to leaders on indication selection, patient populations, clinical endpoints, development sequencing, and program investment decisions.
  • Anticipate future clinical development requirements and identify opportunities to strengthen the company's oncology pipeline, scientific capabilities, development infrastructure, and clinical execution.
  • Support executive and Board-level discussions related to oncology programs, clinical data, development milestones, regulatory strategy, approval pathways, and portfolio decisions, as appropriate.
  • Lead the development and execution of integrated clinical development plans spanning first-in-human studies, dose escalation, proof of concept, pivotal trials, regulatory submission, and post-approval development.
  • Establish scientifically rigorous, operationally executable, and commercially relevant clinical development strategies aligned with regulatory expectations and company objectives.
  • Lead the selection and prioritization of indications, patient populations, treatment settings, clinical endpoints, and development pathways.
  • Develop strategies for transitioning programs from early clinical development into registrational studies, including identification of critical data requirements, regulatory milestones, and development risks.
  • Lead clinical trial design, including dose escalation, dose optimization, expansion cohorts, combination strategies, randomized studies, and pivotal trial approaches, as applicable.
  • Evaluate opportunities for accelerated approval, expedited development pathways, innovative trial designs, and other regulatory strategies that may support efficient advancement toward commercialization.
  • Establish clinical development priorities, milestones, governance, and accountability mechanisms that support efficient program advancement.
  • Partner with Research, Translational Medicine, Regulatory, Clinical Operations, and Commercial leadership to align clinical development plans with scientific, regulatory, and market considerations.
Clinical Trial Design & Execution
  • Provide medical and scientific leadership for oncology clinical trials across the company's development portfolio, from Phase I through pivotal and registrational development.
  • Lead the design of clinical studies capable of generating the safety, efficacy, and other evidence necessary to support development decisions, regulatory submissions, and eventual product approval.
  • Oversee development and review of clinical protocols, investigator brochures, informed consent documents, clinical study reports, and other critical clinical development materials.
  • Ensure early-stage clinical studies are designed not only to establish initial safety and activity but also to inform dose selection, indication prioritization, and subsequent registrational strategies.
  • Provide leadership for pivotal trial design, including patient selection, control arms, primary and secondary endpoints, statistical considerations, and clinically meaningful measures of efficacy.
  • Partner closely with Clinical Operations, Biostatistics, Data Management, Pharmacovigilance, and Regulatory Affairs to support effective study execution.
  • Provide medical oversight of ongoing clinical trials, including patient safety, eligibility considerations, protocol implementation, clinical data review, and emerging benefit-risk assessments.
  • Identify and address clinical development challenges, including enrollment, study design, patient selection, endpoint selection, and protocol amendments.
  • Ensure clinical development activities maintain appropriate scientific rigor, patient safety, regulatory compliance, and operational discipline.
Clinical Data, Scientific Interpretation & Program Advancement
  • Lead the medical and scientific interpretation of clinical trial data, including safety, efficacy, pharmacokinetics, pharmacodynamics, biomarkers, and other relevant clinical outcomes.
  • Translate emerging Phase I and Phase II clinical findings into actionable decisions regarding dose selection, indication expansion, pivotal trial design, and registrational development.
  • Evaluate the strength of clinical evidence and determine whether programs have established an appropriate scientific and regulatory foundation for advancement.
  • Develop strategies to address clinical development uncertainties, including limited early efficacy signals, evolving standards of care, patient heterogeneity, and competitive treatment landscapes.
  • Establish clear clinical decision-making frameworks and development milestones based on scientific evidence, clinical feasibility, regulatory requirements, and commercial objectives.
  • Partner with Biostatistics, Translational Medicine, Clinical Pharmacology, and other scientific functions to develop robust data analysis and interpretation strategies.
  • Provide executive leadership with clear assessments of clinical findings, development opportunities, program risks, and recommended next steps.
  • Lead the clinical interpretation and communication of pivotal study results and their implications for regulatory submissions, labeling, approval, and commercialization.
Regulatory Strategy, BLA Submission & Approval
  • Provide senior clinical and medical leadership for regulatory strategies supporting oncology programs from initial IND submissions through BLA submission, regulatory review, approval, and post-marketing commitments.
  • Lead the development of clinical strategies and evidence-generation plans intended to satisfy FDA and applicable international regulatory requirements for marketing authorization.
  • Partner closely with Regulatory Affairs to establish and execute regulatory engagement strategies, including interactions related to dose selection, pivotal study design, endpoints, and registrational pathways.
  • Serve as a senior clinical representative in regulatory agency interactions, including FDA Type B and other key development meetings, pre‑BLA meetings, advisory committee preparation, and regulatory review discussions, as applicable.
  • Provide leadership and accountability for the clinical components of marketing applications, including integrated summaries of efficacy and safety, clinical study reports, benefit‑risk assessments, and other relevant submission materials.
  • Lead the clinical development organization's preparation for regulatory review, including responses to agency questions, clinical data analyses, and resolution of clinical issues that may affect approval.
  • Partner with Regulatory Affairs, Biostatistics, Pharmacovigilance, and other functions to support successful BLA submission, review, and approval.
  • Provide medical and scientific leadership in discussions concerning product labeling, indicated patient populations, clinical evidence, safety considerations, and post‑marketing requirements.
  • Maintain a strong understanding of evolving oncology regulatory expectations and apply that knowledge to the development of practical, scientifically sound approval strategies.
Commercialization Readiness & Lifecycle Development
  • Provide clinical development leadership supporting the transition of oncology programs from clinical development through regulatory approval and commercial launch.
  • Partner with Medical Affairs, Commercial, Regulatory Affairs, and other functions to ensure clinical development strategies generate evidence relevant to regulatory approval, clinical practice, and eventual product adoption.
  • Support the development of clinically meaningful product differentiation strategies based on efficacy, safety, patient populations, treatment setting, and competitive positioning.
  • Provide medical and scientific input into launch readiness activities, including interpretation of pivotal data, product labeling considerations, and communication of clinical evidence.
  • Ensure appropriate transition of clinical knowledge, development history, safety findings, and scientific rationale to Medical Affairs and other functions supporting commercialization.
  • Develop and oversee clinical strategies for post‑approval studies, additional indications, combination regimens, and other lifecycle management opportunities.
  • Partner with Commercial and Medical Affairs leadership to identify future evidence‑generation needs while maintaining appropriate separation between clinical development, medical, and promotional activities.
  • Support the long‑term clinical development strategy for approved oncology products, including label expansion and continued clinical differentiation.
Medical Monitoring, Patient Safety & Clinical Oversight
  • Provide senior medical oversight of oncology clinical trials, ensuring appropriate attention to patient safety, clinical quality, and scientific integrity.
  • Oversee medical monitoring activities, including review of adverse events, serious adverse events, emerging safety signals, protocol deviations, and relevant clinical data.
  • Partner with Pharmacovigilance and Drug Safety to evaluate safety findings and maintain appropriate benefit‑risk assessments throughout clinical development.
  • Support the development and implementation of safety monitoring strategies, dose modification guidelines, stopping rules, and risk mitigation measures.
  • Provide medical leadership for safety review committees, data monitoring committees, and other clinical governance activities, as appropriate.
  • Ensure timely identification, escalation, and resolution of significant medical and safety concerns.
  • Maintain a patient‑centered approach to clinical development that balances scientific innovation with responsible medical oversight.
External Scientific Leadership & Clinical Partnerships
  • Establish and maintain strong relationships with key opinion leaders, clinical investigators, academic institutions, cooperative groups, and other external scientific partners.
  • Represent the company in scientific discussions, investigator meetings, advisory boards, medical conferences, and other external engagements.
  • Engage external experts to inform clinical development strategy, pivotal trial design, indication selection, and interpretation of emerging scientific data.
  • Develop relationships with investigators and scientific leaders capable of supporting programs from early clinical research through registrational development.
  • Partner with Clinical Operations and other functions to evaluate clinical trial sites, investigator capabilities, and opportunities to strengthen trial execution.
  • Support strategic scientific collaborations and external development opportunities that advance the company's oncology pipeline.
  • Serve as a credible scientific and medical representative of the organization with investigators, regulatory authorities, and external stakeholders.
Clinical Development Operations, Systems & Execution
  • Ensure oncology clinical development processes, governance, and operating rhythms effectively support a growing global biotechnology organization.
  • Establish meaningful performance measures covering clinical development milestones, study progress, enrollment, data quality, medical monitoring, regulatory readiness, and program execution.
  • Partner with Clinical Operations to ensure appropriate study planning, resource allocation, vendor oversight, and execution against development timelines.
  • Develop integrated clinical development timelines that account for pivotal study execution, database lock, clinical data analysis, regulatory submission preparation, and anticipated review milestones.
  • Identify opportunities to streamline clinical development processes and improve cross‑functional coordination without introducing unnecessary bureaucracy.
  • Maintain appropriate medical documentation, clinical oversight, data integrity, and regulatory compliance across development activities.
  • Balance scientific rigor, operational efficiency, and thoughtful risk‑taking to advance clinical programs in a fast‑moving biotechnology environment.
Cross-Functional Leadership
  • Serve as a highly collaborative cross‑functional leader who connects clinical development strategy with scientific research, regulatory planning, operational execution, and broader company objectives.
  • Build strong partnerships across Research, Translational Medicine, Clinical Operations, Regulatory Affairs, Biostatistics, Pharmacovigilance, Medical Affairs, CMC, and Commercial functions.
  • Communicate clinical development progress, scientific findings, program risks, trade‑offs, and strategic decisions clearly to executive and functional leadership.
  • Build, develop, and lead a high‑performing oncology clinical development organization with the medical expertise, scientific capabilities, and operational discipline necessary to support continued growth.
  • Establish clear responsibilities, decision‑making processes, and accountability across internal teams and external partners.
  • Serve as a visible, accessible, and credible clinical development leader across the company and within the broader oncology community.
Required Qualifications
  • Medical degree (MD) with significant oncology clinical development leadership experience within the biotechnology or pharmaceutical industry.
  • Demonstrated leadership experience advancing oncology clinical development programs from Phase I through pivotal or registrational development, BLA submission, regulatory approval, and commercialization.
  • Proven ability to develop and execute comprehensive oncology clinical development strategies that establish a viable path from first‑in‑human studies to regulatory approval.
  • Direct experience leading pivotal or registrational oncology clinical trials, including responsibility for clinical strategy, study design, execution, data interpretation, and regulatory readiness.
  • Substantial involvement in a successful oncology marketing application and regulatory approval, with a clear understanding of the clinical development activities required to support BLA submission, agency review, and approval.
  • Demonstrated ability to interpret early clinical efficacy and safety data, identify promising indications, select appropriate doses and patient populations, and translate Phase I findings into actionable registrational development strategies.
  • Strong understanding of oncology clinical trial design, clinical endpoints, dose optimization, patient selection, safety assessment, benefit‑risk evaluation, and the evolving oncology treatment landscape.
  • Experience leading clinical development interactions with the FDA, including discussions concerning pivotal study design, regulatory pathways, clinical data requirements, and marketing application readiness.
  • Experience supporting clinical development activities through product approval and commercial launch, including collaboration with Medical Affairs, Commercial, Regulatory Affairs, and other functions.
  • Demonstrated ability to develop clinical strategies supporting accelerated approval, traditional approval, and other applicable regulatory pathways.
  • Strong understanding of FDA and international regulatory expectations, GCP requirements, and clinical development practices.
  • Demonstrated ability to interpret complex oncology clinical data and translate emerging findings into clear development strategies and business decisions.
  • Experience leading clinical development activities within a global biotechnology or pharmaceutical organization, preferably with commercial‑stage experience.
  • Demonstrated experience partnering directly with senior executives on clinical development strategy, scientific opportunities, regulatory pathways, and business‑critical decisions.
  • Established credibility within the oncology clinical research community, with experience engaging key opinion leaders, investigators, academic institutions, and external scientific advisors.
  • Experience building, scaling, or evolving clinical development teams, processes, capabilities, and infrastructure within a growing organization.
  • Strong business and financial acumen and the ability to evaluate clinical development decisions within the broader context of company strategy, patient needs, competitive positioning, and financial performance.
  • Demonstrated ability to operate effectively in a fast‑moving, entrepreneurial environment where priorities can evolve quickly.
  • Strong leadership, communication, and interpersonal skills, with the ability to influence across functions and organizational levels.
  • Board certification or advanced clinical training in Oncology, Hematology/Oncology, or a related specialty preferred.
Location Preference

Preference will be given to candidates who are currently based in Pennsylvania or willing to relocate to Pennsylvania. However, the company recognizes the specialized nature of this role and is open to considering highly qualified candidates in other locations.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Medical Director, Clinical Development
Medical Director, Clinical Development

Ultimate Source Recruiting • San Francisco (CA)

On-site
USD 250,000 - 350,000
Medical Director
Medical Director

Lancesoft • Cambridge (MA)

On-site
USD 260,000 - 380,000
Senior Medical Director, Global Clinical Development, Oncology
Senior Medical Director, Global Clinical Development, Oncology

Barrington James • Massachusetts

On-site
USD 260,000 - 380,000
Oncology Clinical Development Medical Director
Oncology Clinical Development Medical Director

Lancesoft • Durham (NC)

Remote
USD 250,000 - 350,000
Senior Medical Director, Clinical Development & Safety, Oncology-632163
Senior Medical Director, Clinical Development & Safety, Oncology-632163

Planet Pharma • Massachusetts

On-site
USD 250,000 - 360,000
Senior Director Clinical Development
Senior Director Clinical Development

BioPhase • United States

Remote
USD 250,000 - 450,000
Medical Director, Oncology Clinical Development - Hematology
Medical Director, Oncology Clinical Development - Hematology

Glaxosmithkline • United States

Hybrid
USD 186,000 - 266,000
Development Physician, (Remote)
Development Physician, (Remote)

Belcan • United States

On-site
USD 150,000 - 200,000
Executive Director, Clinical Development
Executive Director, Clinical Development

Warman O'Brien • United States

On-site
USD 200,000 - 250,000
Senior Medical Director, Early Development Oncology
Senior Medical Director, Early Development Oncology

Hydrogen Group • Boston (MA)

On-site
USD 250,000 - 360,000